I’m sure it’s purely a ‘coincidence’ as the New York Times would have you believe, but shortages of critical drugs are getting worse under ObamaCARE, and doctors are scrambling to find alternatives.
“We are at a public health crisis when we don’t have the medicines to treat acutely ill patients and we don’t have the basics like intravenous fluids,” said Erin Fox, a drug expert at the University of Utah whose data was used in report. The most acute shortage now is that of basic I.V. fluids, she said.
The drug industry rarely spells out the precise reason for a shortage, citing its need to protect competitive trade information.
Dr. Douglas C. Throckmorton, a senior F.D.A. official who deals with shortages, said in written testimony released on Monday that 66 percent of production disruptions that led to shortages were caused by quality problems and efforts to fix them.
The 2012 law required that drug companies provide the F.D.A. with a general reason, but Ms. Fox said that it was often not specific enough to understand what was driving the shortage.